GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,317,000 | +2.2% | 53,226 | +2.3% | 0.08% | +18.6% |
Q1 2022 | $2,267,000 | +2.0% | 52,046 | +3.3% | 0.07% | +6.1% |
Q4 2021 | $2,222,000 | +14.0% | 50,379 | -1.2% | 0.07% | +1.5% |
Q3 2021 | $1,949,000 | -0.4% | 50,994 | +3.8% | 0.06% | 0.0% |
Q2 2021 | $1,956,000 | +7.9% | 49,123 | -3.3% | 0.06% | +3.2% |
Q1 2021 | $1,812,000 | -15.0% | 50,785 | -12.3% | 0.06% | -23.2% |
Q4 2020 | $2,131,000 | -25.2% | 57,889 | -23.5% | 0.08% | -33.3% |
Q3 2020 | $2,849,000 | -10.7% | 75,683 | -3.2% | 0.12% | -20.1% |
Q2 2020 | $3,189,000 | +0.1% | 78,194 | -7.1% | 0.15% | -18.5% |
Q1 2020 | $3,187,000 | -19.2% | 84,135 | +0.2% | 0.19% | +0.5% |
Q4 2019 | $3,945,000 | +10.3% | 83,957 | +0.2% | 0.19% | +2.2% |
Q3 2019 | $3,577,000 | +9.6% | 83,828 | +2.8% | 0.18% | +2.2% |
Q2 2019 | $3,265,000 | -7.7% | 81,573 | -3.6% | 0.18% | -11.8% |
Q1 2019 | $3,538,000 | +9.4% | 84,652 | -0.0% | 0.20% | -1.9% |
Q4 2018 | $3,235,000 | -12.8% | 84,683 | -8.3% | 0.21% | -0.5% |
Q3 2018 | $3,711,000 | -4.5% | 92,383 | -4.1% | 0.21% | -11.4% |
Q2 2018 | $3,884,000 | +2.9% | 96,349 | -0.3% | 0.24% | -9.6% |
Q1 2018 | $3,774,000 | +14.2% | 96,597 | +3.7% | 0.26% | +17.6% |
Q4 2017 | $3,304,000 | -11.4% | 93,139 | +1.4% | 0.22% | -16.9% |
Q3 2017 | $3,728,000 | +2.0% | 91,829 | +8.3% | 0.27% | -2.2% |
Q2 2017 | $3,655,000 | -34.5% | 84,756 | -35.9% | 0.27% | -35.6% |
Q1 2017 | $5,576,000 | +13.2% | 132,266 | +3.4% | 0.42% | +8.2% |
Q4 2016 | $4,924,000 | -16.8% | 127,865 | -6.9% | 0.39% | -23.0% |
Q3 2016 | $5,921,000 | -1.4% | 137,289 | -0.9% | 0.51% | -3.8% |
Q2 2016 | $6,007,000 | +10.4% | 138,605 | +3.3% | 0.53% | +4.3% |
Q1 2016 | $5,440,000 | +86.8% | 134,156 | +85.9% | 0.51% | +88.5% |
Q4 2015 | $2,912,000 | +12.6% | 72,160 | +7.2% | 0.27% | -7.6% |
Q3 2015 | $2,587,000 | -15.2% | 67,292 | -8.1% | 0.29% | -9.9% |
Q2 2015 | $3,050,000 | -4.8% | 73,230 | +5.5% | 0.32% | -5.8% |
Q1 2015 | $3,203,000 | +15.7% | 69,399 | +7.1% | 0.34% | +15.1% |
Q4 2014 | $2,769,000 | -10.8% | 64,814 | -4.1% | 0.30% | -16.3% |
Q3 2014 | $3,106,000 | -1.1% | 67,552 | +15.0% | 0.36% | -1.1% |
Q2 2014 | $3,142,000 | +17.0% | 58,750 | +16.9% | 0.36% | +9.1% |
Q1 2014 | $2,685,000 | -28.5% | 50,262 | -28.6% | 0.33% | -33.1% |
Q4 2013 | $3,757,000 | +7.9% | 70,380 | +1.4% | 0.49% | -8.0% |
Q3 2013 | $3,483,000 | +5.5% | 69,421 | +5.0% | 0.54% | -0.7% |
Q2 2013 | $3,302,000 | – | 66,087 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |